We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

118 hedge funds and large institutions have $241M invested in SANGAMO THERAPEUTICS INC in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 40 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more capital invested

Capital invested by funds: $127M → $241M (+$114M)

57% more call options, than puts

Call options by funds: $3.91M | Put options by funds: $2.49M

0.56% more ownership

Funds ownership: 58.69% → 59.26% (+0.56%)

9% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 22

6% less funds holding

Funds holding: 126 → 118 (-8)

28% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 40

Holders
118
Holders Change
-8
Holders Change %
-6.35%
% of All Funds
2.94%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
29
Reduced
40
Closed
22
Calls
$3.91M
Puts
$2.49M
Net Calls
+$1.42M
Net Calls Change
-$669K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$22.5M
2
CC
Casdin Capital
New York
+$3.41M
3
GIM
Granahan Investment Management
Massachusetts
+$3.19M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.01M
5
BBA
Baker Bros. Advisors
New York
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$2.16M
2
NC
Nexthera Capital
New York
-$1.53M
3
Deutsche Bank
Deutsche Bank
Germany
-$1.12M
4
Renaissance Technologies
Renaissance Technologies
New York
-$982K
5
WA
Wasatch Advisors
Utah
-$787K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$1.54M +$137K +34,128 +13%
TCIM
27
TIAA CREF Investment Management
New York
$1.46M -$29.8K -7,429 -3%
CS
28
Candriam SCA
Luxembourg
$1.4M +$281K +70,000 +35%
USAA
29
United Services Automobile Association
Texas
$1.39M +$1.08M +268,100 New
Charles Schwab
30
Charles Schwab
California
$1.38M +$56.2K +14,022 +6%
Millennium Management
31
Millennium Management
New York
$1.14M -$59.7K -14,872 -6%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$1.07M -$615K -153,334 -43%
TA
33
Teachers Advisors
New York
$940K +$64.7K +16,130 +10%
IHM
34
Iguana Healthcare Management
New York
$780K +$602K +150,000 New
QI
35
QS Investors
New York
$755K – – –
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$711K -$24.5K -6,100 -4%
KeyBank National Association
37
KeyBank National Association
Ohio
$703K – – –
Ohio Public Employees Retirement System (OPERS)
38
Ohio Public Employees Retirement System (OPERS)
Ohio
$700K – – –
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$670K +$2.06K +513 +0.4%
T. Rowe Price Associates
40
T. Rowe Price Associates
Maryland
$667K -$60.2K -15,000 -10%
Group One Trading
41
Group One Trading
Illinois
$602K -$292K -72,765 -39%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$594K -$20.1K -5,000 -4%
Swiss National Bank
43
Swiss National Bank
Switzerland
$591K – – –
PPA
44
Parametric Portfolio Associates
Washington
$578K +$446K +111,136 New
PP
45
PDT Partners
New York
$556K +$86.6K +21,600 +25%
HCM
46
Highbridge Capital Management
New York
$496K +$382K +95,287 New
AllianceBernstein
47
AllianceBernstein
Tennessee
$469K -$40.9K -10,200 -10%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$449K -$617K -153,705 -64%
WMSA
49
Weiss Multi-Strategy Advisers
New York
$442K – – –
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$442K +$10.2K +2,549 +3%
1
2
3 4 5

SGMO Hedge Fund Activity: Q1 2017 in Review

118 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2017, worth a combined $241M — up 90% from $127M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of SGMO and 20 opened new positions — a net loss of 2 holders — while 40 trimmed existing stakes and 29 added.

The largest buyer was BlackRock, adding an estimated $22.5M. The largest seller was OrbiMed, exiting entirely with an estimated $2.16M sold.

  • 118 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2017, down from 126 in Q4 2016.
  • Funds reported $241M of SANGAMO THERAPEUTICS INC stock for Q1 2017, up 90% quarter-over-quarter.
  • 20 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2017 and 22 closed out, a net change of -2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2017 was BlackRock, an estimated $22.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2017 was OrbiMed, an estimated $2.16M sold.

Based on aggregated 13F filings for Q1 2017.